Biotechnology Instrument Market
Biotechnology Instrument Market Study by Lab Automation Instruments, Medical Lasers, and Life Science Consumables from 2024 to 2034
Analysis of Biotechnology Instrument Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Biotechnology Instrument Market Outlook (2024 to 2034)
The global biotechnology instrument market is calculated at US$ 67.24 billion in 2024, as revealed in the updated market research report by Fact.MR. Worldwide sales of biotechnology instruments are evaluated to accelerate at 12.5% CAGR and reach US$ 218.11 billion by the end of 2034.
There has been a steady increase in the cases of chronic diseases such as cancer, diabetes, and cardiovascular diseases around the world. As such, need for efficient diagnostic techniques has been increasing in parallel. Constant advancements in biotechnology are driving demand for biotechnology instruments for effective operation.
Increasing demand for point-of-care devices/tests is contributing to the rising sales of biotechnology instruments. These instruments are employed in the biotechnology field for multiple applications. They play a vital role in analyzing biomolecules, conducting experiments, and operating biological systems to conduct biotechnological research.
Governments in several countries, including China and the United States, are constantly investing to strengthen their life science and biotechnology sectors. They are involved in framing favorable policies and offering funding for R&D activities conducted in the biotech and pharmaceutical sectors. In addition, there is a growing adoption of biotechnology instruments for increasing productivity and streamlining workflow with the automation of repetitive tasks such as sample handling and analysis.
There is also growing use of biotechnology instruments by industry professionals and researchers for exploring the complexities of biotechnology systems. These instruments are also used for harnessing the complete potential for societal benefits and innovations.
- Global sales of biotechnology lab automation instruments are projected to climb at 12.8% CAGR and reach US$ 112.67 billion by the end of 2034.
- Demand for biotechnology instruments in Japan is analyzed to accelerate at a CAGR of 5.1% from 2024 to 2034.
- Sales of biotechnology instruments in China are evaluated to rise at a high-value CAGR of 16.9% and reach US$ 24.49 billion by 2034-end.
| Report Attribute | Detail |
|---|---|
| Biotechnology Instrument Market Size (2024E) | US$ 67.24 Billion |
| Forecasted Market Value (2034F) | US$ 218.11 Billion |
| Global Market Growth Rate (2024 to 2034) | 12.5% CAGR |
| Market Share of Pharmaceutical & Biotechnology Companies (2034F) | 37% |
| South Asia & Pacific Market Share (2034F) | 21.6% |
| Canada Market Growth Rate (2024 to 2034) | 18.5% CAGR |
| Key Companies Profiled | Waters Corporation; F. Hoffmann-La Roche Ltd.; Abbott; Zimmer MedizinSysteme; Agilent Technologies; Thermo Fisher Scientific, Inc.; BioMerieux SA; Siemens Healthineers; Bio-Rad Laboratories; Perkin Elmer, Inc.; BioTek Instruments, Inc.; Novanta, Inc.; Candela Medical; Merck KGaA; Cynosure, LLC; IIlumina Inc.; Danaher Corporation. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Key Drivers are Responsible for Global Market Expansion?
“Growing Prevalence of Target Diseases Augmenting Demand for Biotechnology Instruments”
One of the prominent biotechnology instrument market growth drivers is increasing cases of chronic diseases around the world. These health issues lead to the rising need for surgical procedures, which is contributing to the increasing demand for biotechnology instruments. Healthcare professionals are actively looking for instruments with high sensitivity, specificity, and accuracy, customized to match their unique clinical requirements. Dependability and quality of biotechnology instruments are contributing to their increased adoption in the healthcare sector.
“Rising Demand for POC (Point-of-Care) Tests”
Rising requirements for POC tests across the globe are contributing to the increased sales of biotechnology instruments. These devices are used for identifying parameters of various conditions such as thyroid function, cardiac markets, fertility, diabetes, metabolic markers, inflammation, and coagulation markers. These instruments are used in diagnostic ecosystems for carrying out accurate and reliable tests at economic prices, thereby helping in rapid decision-making.
Which Drawbacks of Biotechnology Instruments are Manufacturers Expected to Work More On?
“Growing Concerns about Malfunctioning of Tools and Availability of Counterfeit Instruments”
Increasing public concerns about genetically modified crops and their adverse effects on human health are limited by the use of biotechnology tools. Even a slight possibility of the leakage of hazardous bacteria and viruses from research facilities cast doubt on the efficiency of biotechnology tools. In addition, these instruments are also utilized for creating deadly viruses, which are resulting in detrimental effects on human health, which is a key, negative biotechnology instrument market trend.
Increasing popularity of biotechnology instruments has led to the development of various counterfeit instruments, which poses a risk while handling hazardous bacteria. These issues are limiting the opportunities for suppliers of branded instruments.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What New Approaches are Startups Using to Establish Themselves in the Market?
“High Investments in Developing More Effective and Safer Biotechnology Instruments”
New market players are leveraging opportunities created by the rising preference for medical tools or instruments with improved efficiency and safety. They are actively involved in manufacturing biotechnology instruments with high-level multiplexing for the detection of various infectious diseases, thereby making them more suitable for syndromic testing.
Country-wise Insights
Fact.MR, a market research and competitive intelligence provider, in its recently updated industry analysis, reveals that North America is projected to account for 35.6% of the global biotechnology instrument market share by the end of 2034. Growing demand for affordable biotechnology instruments in the region is generating remunerative opportunities for market players. Popular trend of manual mechanization in pharmaceutical biotechnology is driving the demand for more effective equipment with ease of operation.
Why are Biotechnology Instruments Gaining Traction in the United States?
“Presence of Biotech Institutions Resulting in Growing Use of Biotechnology Instruments in Research Activities”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 20.72 Billion |
| Growth Rate (2024 to 2034) | 14.1% CAGR |
| Projected Value (2034F) | US$ 77.44 Billion |
The United States is evaluated to capture 80.3% share of the market in North America by the end of 2034. The country is home to well-known biotech institutions such as the Massachusetts Institute of Technology, Cambridge. These institutes are constantly involved in research activities related to gene expression, thereby creating prospects for manufacturers of biotechnology instruments.
Why are There Increased Requirements for Biotechnology Instruments in India?
“Rising Investments in Biotech Research Activities”
| Attribute | India |
|---|---|
| Market Value (2024E) | US$ 3.25 Billion |
| Growth Rate (2024 to 2034) | 18.4% CAGR |
| Projected Value (2034F) | US$ 17.65 Billion |
India is approximated to occupy 66.7% share of the South Asia & Pacific market by the end of 2034. In recent years, there has been a considerable increase in R&D activities conducted in the biotech industry, which is generating prospects for suppliers of biotechnology instruments. With the economy growing and high focus being given to the healthcare sector, the country is set to emerge as a key market over the coming years.
What is Responsible for Growing Prominence of Biotechnology Instruments in South Korea?
“Increasing Burden of Target Diseases”
| Attribute | South Korea |
|---|---|
| Market Value (2024E) | US$ 2.41 Billion |
| Growth Rate (2024 to 2034) | 13.1% CAGR |
| Projected Value (2034F) | US$ 8.27 Billion |
South Korea is analyzed to hold 21% share of the market in East Asia by 2034-end. In recent years, an increase in the cases of Alzheimer's disease, cancer, and cardiovascular diseases has been registered in the country, which is generating demand for more advanced diagnostic tests, and subsequently, biotechnology instruments.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Recently updated report by Fact.MR asserts that increasing demand for biotechnology lab automation instruments is owing to their precise handling capabilities. These instruments are used extensively to match high accuracy requirements in laboratory procedures, which is further contributing to the expanding biotechnology instrument market size.
Which Component of Biotechnology Instruments is Used More?
“Rising Use of Biotechnology Lab Automation Instruments for Laboratory Processes without Frequent Monitoring and Maintenance Requirements”
| Attribute | Biotechnology Lab Automation Instruments |
|---|---|
| Segment Value (2024E) | US$ 33.78 Billion |
| Growth Rate (2024 to 2034) | 12.8% CAGR |
| Projected Value (2034F) | US$ 112.67 Billion |
Biotechnology lab automation instruments are projected to account for a market share of 51.7% by the end of 2034. These instruments are used in genomics, proteomics, spatial cell analysis, and sequencing, which is further contributing to their increased demand. Growing requirements for biotechnology lab automation instruments are attributed to their feature of independent operation without human intervention. They work for extended times without the need for frequent maintenance and monitoring.
Which End User is Generating Remunerative Opportunities for Market Players?
“Surging Use of Biotechnology Instruments in Pharmaceutical & Biotechnology Companies”
| Attribute | Pharmaceutical & Biotechnology Companies |
|---|---|
| Segment Value (2024E) | US$ 25.94 Billion |
| Growth Rate (2024 to 2034) | 12% CAGR |
| Projected Value (2034F) | US$ 80.61 Billion |
Pharmaceutical & biotechnology companies are evaluated to capture 37% of the global market revenue share by 2034. State-of-the-art manufacturing processes and instruments are required in the development of niche biotechnology-derived drugs. Rising prominence of biopharmaceuticals is contributing to the growing demand for safer and more effective biotechnology instruments. Refining operation effectiveness with the use of the best possible equipment and implementation of flexible and new systems help biopharmaceutical companies reduce production costs and improve on product innovations.
Competitive Landscape
Key players in the biotechnology instrument market are actively involved in new product development, offering quality products, and management of supply chain systems. They are constantly putting efforts into innovations to ensure the supply of more effective instruments.
For instance :
- Lumenis, in July 2021, came up with Next-generation Holmium Laser Technology, MOSES 2.0. This technology will increase the effectiveness of the operation of enlarged prostate and urinary stones. The company is offering energy-based medical devices for use in surgical, ophthalmic, and aesthetic applications.
Fact.MR provides detailed information about the price points of key manufacturers of biotechnology instruments positioned across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.
Segmentation of Biotechnology Instrument Market Research
-
By Component :
- Biotechnology Lab Automation Instruments
- Biotechnology Medical Lasers
- Biotechnology Life Science Consumables
-
By End User :
- Government & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Healthcare Facilities
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- MEA
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Component 6.2. End Use 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Component 7.1. Biotechnology Lab Automation Instruments 7.2. Biotechnology Medical Lasers 7.3. Biotechnology Life Science Consumables 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 8.1. Government & Academic Institutes 8.2. Pharmaceutical & Biotechnology Companies 8.3. Hospitals & Healthcare Facilities 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. East Asia 9.6. South Asia & Pacific 9.7. Middle East & Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 by Component, End Use, and Region for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Waters Corporation 19.2. F. Hoffmann-La Roche Ltd. 19.3. Abbott 19.4. Zimmer MedizinSysteme 19.5. Agilent Technologies 19.6. Thermo Fisher Scientific, Inc. 19.7. BioMerieux SA 19.8. Siemens Healthineers 19.9. Bio-Rad Laboratories 19.10. Perkin Elmer, Inc. 19.11. BioTek Instruments, Inc. 19.12. Novanta, Inc. 19.13. Candela Medical 19.14. Merck KGaA 19.15. Cynosure, LLC 19.16. IIlumina Inc. 19.17. Danaher Corporation 20. Assumptions and Acronyms Used 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 10: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 11: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 12: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 19: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: Latin America Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 23: Latin America Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 24: Latin America Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 28: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 29: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 30: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 31: Western Europe Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 32: Western Europe Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 33: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 34: Western Europe Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 35: Western Europe Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 36: Western Europe Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 37: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Eastern Europe Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 41: Eastern Europe Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 42: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 43: Eastern Europe Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 44: Eastern Europe Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 45: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 46: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 55: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: South Asia & Pacific Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 59: South Asia & Pacific Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 60: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 61: South Asia & Pacific Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 62: South Asia & Pacific Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 63: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
Table 64: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 65: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 66: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 67: MEA Market Value (US$ Mn) Analysis, by Component, 2019 to 2023
Table 68: MEA Market Value (US$ Mn) Analysis, by Component, 2024 to 2034
Table 69: MEA Market Value (US$ Mn) Opportunity Analysis, by Component, 2024 to 2034
Table 70: MEA Market Value (US$ Mn) Analysis, by End Use, 2019 to 2023
Table 71: MEA Market Value (US$ Mn) Analysis, by End Use, 2024 to 2034
Table 72: MEA Market Value (US$ Mn) Opportunity Analysis, by End Use, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Component, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Component, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 14: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 15: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 16: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 17: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 18: North America Market Share Analysis by Country, 2024 & 2034
Figure 19: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 20: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 21: North America Market Share and BPS Analysis by Component, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Component, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 27: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 28: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 29: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 30: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 31: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 32: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 33: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 34: Latin America Market Share and BPS Analysis by Component, 2024 & 2034
Figure 35: Latin America Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 36: Latin America Market Attractiveness Analysis by Component, 2024 to 2034
Figure 37: Latin America Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 40: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 41: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 42: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 43: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 44: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 45: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 46: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 47: Western Europe Market Share and BPS Analysis by Component, 2024 & 2034
Figure 48: Western Europe Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 49: Western Europe Market Attractiveness Analysis by Component, 2024 to 2034
Figure 50: Western Europe Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 51: Western Europe Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 52: Western Europe Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 53: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 54: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 55: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 56: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 57: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 58: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 59: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 60: Eastern Europe Market Share and BPS Analysis by Component, 2024 & 2034
Figure 61: Eastern Europe Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 62: Eastern Europe Market Attractiveness Analysis by Component, 2024 to 2034
Figure 63: Eastern Europe Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 64: Eastern Europe Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 65: Eastern Europe Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 66: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 70: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 71: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: East Asia Market Share and BPS Analysis by Component, 2024 & 2034
Figure 74: East Asia Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 75: East Asia Market Attractiveness Analysis by Component, 2024 to 2034
Figure 76: East Asia Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 77: East Asia Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 78: East Asia Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 79: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 80: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 81: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 82: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 83: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 84: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 85: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 86: South Asia & Pacific Market Share and BPS Analysis by Component, 2024 & 2034
Figure 87: South Asia & Pacific Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 88: South Asia & Pacific Market Attractiveness Analysis by Component, 2024 to 2034
Figure 89: South Asia & Pacific Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 90: South Asia & Pacific Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 91: South Asia & Pacific Market Attractiveness Analysis by End Use, 2024 to 2034
Figure 92: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 93: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 94: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 95: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 96: MEA Market Share Analysis by Country, 2024 & 2034
Figure 97: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 98: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 99: MEA Market Share and BPS Analysis by Component, 2024 & 2034
Figure 100: MEA Market Y-o-Y Growth Projections by Component, 2024 to 2034
Figure 101: MEA Market Attractiveness Analysis by Component, 2024 to 2034
Figure 102: MEA Market Share and BPS Analysis by End Use, 2024 & 2034
Figure 103: MEA Market Y-o-Y Growth Projections by End Use, 2024 to 2034
Figure 104: MEA Market Attractiveness Analysis by End Use, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the biotechnology instrument market in 2024?
The global biotechnology instrument market is calculated at US$ 67.24 billion in 2024.
What are the sales projections for biotechnology instruments for 2034?
Global sales of biotechnology instruments are forecasted to reach US$ 218.11 billion by 2034.
At what CAGR is the demand for biotechnology instruments forecasted to accelerate?
The global market is projected to expand at a CAGR of 12.5% from 2024 to 2034.
What is the contribution of North America to global market revenue?
North America is evaluated to capture 35.6% of the global market share by 2034.
At what rate is the demand for biotechnology instruments evaluated to increase in South Korea?
The market in South Korea is calculated to accelerate at 13.1% CAGR from 2024 to 2034.
How much share of the market are biotechnology lab automation instruments analyzed to account for?
Biotechnology lab automation instruments are approximated to capture 51.7% of global market revenue by 2034.
Who are some of the leading manufacturers of biotechnology instruments?
Waters Corporation, F. Hoffmann-La Roche Ltd., Abbott, Zimmer MedizinSysteme, and Agilent Technologies are leading manufacturers of biotechnology instruments.
Biotechnology Instrument Market